Glenmede Trust CO Na Horizon Therapeutics Public LTD CO Transaction History

Glenmede Trust CO Na

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2020 Feb 16, 2021	SELL	$67.0 - $84.39 $25,996 - $32,743	-388 Closed	0 $0
Q3 2020 Nov 16, 2020	SELL	$55.23 - $79.93 $36 Million - $52.1 Million	-652,194 Reduced 99.94%	388 $30,000
Q2 2020 Aug 14, 2020	SELL	$30.2 - $56.98 $21.9 Million - $41.3 Million	-725,010 Reduced 52.63%	652,582 $36.3 Million
Q4 2019 Feb 12, 2020	SELL	$25.43 - $36.67 $4.54 Million - $6.55 Million	-178,641 Reduced 11.48%	1,377,592 $49.9 Million
Q3 2019 Nov 14, 2019	SELL	$23.0 - $27.97 $2.99 Million - $3.64 Million	-130,116 Reduced 7.72%	1,556,233 $42.4 Million

Q2 2019 Aug 13, 2019	BUY	$22.81 - $28.48 $38.5 Million - $48 Million	1,686,349 New	1,686,349 $40.6 Million

2.07M

20K

Ticker HZNP
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 230,384,000
Description
Horizon Therapeutics Public Limited Company, a biotechnology company, focuses on the discovery, development, and commercialization of medicines that address critical needs for people impacted by rare, autoimmune, and severe inflammatory diseases. The company operates in two segments, Orphan and Inflammation. Its portfolio comprises 12 medicines ...

Get notified when there are updates to the investment portfolio of Glenmede Trust CO Na, based on Form 13F filings with the SEC.

Stay updated on Glenmede Trust CO Na with notifications on news.